Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 2,230 shares at $274.42 ($625K) on 2020-09-29, disclosed to the SEC on 2020-10-01.
Open-market sale of $625k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $274.42 | 200 | $55K | 8.8% |
| 2 | $280.65 | 730 | $205K | 32.8% |
| 3 | $280.65 | 730 | $205K | 32.8% |
| 4 | $281.75 | 468 | $132K | 21.1% |
| 5 | $283.83 | 102 | $29K | 4.6% |
| Total | $280.47 avg | 2,230 |
| $625K |
| 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |